February 5, 2019

There’s an old saying in investing – “Follow the trend”.  But of course, the hard part is in knowing how far along we are in the trend. Naturally, it’s better to get in early, rather than late, and in my view, emerging technologies represent a great opportunity for early stage exposure to a long and promising trend. Recent cooling in sentiment towards broader technology, along with more reasonable valuations in a rapidly growing area, make this a good entry to a sector that has the potential to outperform for years to come.

With technology investing, volatility is currently the norm, and clearly, the broader uptrend in global equities ran into trouble in late 2018. In December, there were indeed few places to hide as nine out of 10 asset classes retreated. Technology plays that had dominated index performances for years finally pulled back in a significant way, which in my view, presents interesting opportunities for investors who still believe in some of the fundamental stories that underpinned these rallies.

Will Amazon continue to dominate online retail and cloud services? Probably. Will Apple continue to be the Scrooge McDuck cash-hoarding machine it has been for a decade? Well, perhaps not as much. So while I believe that opportunity still abounds, I also feel that a new environment is upon us – one in which investors need to be more selective, even in the technology sector.

The broader trend that I feel will hold strong going forward is that technology will continue to pervade throughout the fabric of most industries. It affects how we communicate, transact, work and play. It is inescapable and has come to affect most facets of our lives. Let’s face it, technology is forming the foundation for life in the modern world, and astute companies are realizing that virtually all companies need to, at least in part, be technology firms. To not understand this fact is to risk falling behind, missing opportunities or perhaps ensuring one’s demise.

Much of modern technology, per se, is not new. What is relatively recent is the impact that big data and computation power are having in the areas of artificial intelligence (A.I.) and advanced robotics. As I wrote in a previous blog on data proliferation, much of it comes from high mobile phone penetration and usage. Computation power, that can quickly make sense of this data in a myriad of amazing ways, has expanded greatly. Machine learning is being driven by an avalanche of information and quick processors that enables it to draw conclusions that are more accurate and informative than we could have ever imagined just a few years ago.

As an example, A.I. is transforming healthcare by helping surgeons and physicians to make smarter decisions at the point of contact. Algorithms are highlighting problem areas on MRIs and X-rays, which improves accuracy and reduces physician fatigue. Want to invest in that? You can, but in this fast-moving area, I would suggest doing so by buying a fund that diversifies your risk across leading companies in a space that includes key categories such as Advanced Robotics, Augmented Reality and Cloud & Big Data. RBOT and FOUR do just that. And with the recent weakness in the broader technology space, it’s a great time to consider buying these companies on sale.

On January 17, 2019, Bloomberg reported that Apple will likely cut back on hiring new employees in many of its divisions – but not in the area of artificial intelligence. This isn’t surprising. Our RBOT holding, Intuitive Surgical (“ISRG”), pre-announced better-than-expected revenues on January 9. Further, on January 30, Alibaba (“BABA”) announced weak revenue growth but said it continues to invest heavily in cloud computing and artificial intelligence.

In these uncertain times, make sure to look for tech trends that have staying power.

The views/opinions expressed herein may not necessarily be the views of Horizons ETFs Management (Canada) Inc. All comments, opinions and views expressed are of a general nature and should not be considered as advice to purchase or to sell mentioned securities. Before making any investment decision, please consult your investment advisor or advisors.

Share This Article

Next article

Gold: Checking the Boxes for HGY and HEP

This website uses cookies to ensure we give you the best experience. By continuing to browse the site, you are agreeing to our use of cookies. Click here to read our privacy policy.

Commissions, management fees and expenses all may be associated with an investment in exchange traded products managed by Horizons ETFs Management (Canada) Inc. (the "Horizons Exchange Traded Products"). The Horizons Exchange Traded Products are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Horizons Exchange Traded Products. Please read the relevant prospectus before investing.

The Horizons Exchange Traded Products include our BetaPro products (the “BetaPro Products”). The BetaPro Products are alternative mutual funds within the meaning of National Instrument 81-102 Investment Funds, and are permitted to use strategies generally prohibited by conventional mutual funds: the ability to invest more than 10% of their net asset value in securities of a single issuer, to employ leverage, and engage in short selling to a greater extent than is permitted in conventional mutual funds. While these strategies will only be used in accordance with the investment objectives and strategies of the BetaPro Products, during certain market conditions they may accelerate the risk that an investment in units of a BetaPro Product decreases in value. The BetaPro Products consist of our 2x Daily Bull and 2x Daily Bear ETFs (“2x Daily ETFs”), Inverse ETFs (“Inverse ETFs”) and our BetaPro S&P 500 VIX Short-Term Futures™ ETF (the “VIX ETF”). Included in the 2x Daily ETFs and the Inverse ETFs are the BetaPro Marijuana Companies 2x Daily Bull ETF (“HMJU”) and BetaPro Marijuana Companies Inverse ETF (“HMJI”), which track the North American MOC Marijuana Index (NTR) and North American MOC Marijuana Index (TR), respectively. The 2x Daily ETFs and certain other BetaPro Products use leveraged investment techniques that can magnify gains and losses and may result in greater volatility of returns. These BetaPro Products are subject to leverage risk and may be subject to aggressive investment risk and price volatility risk, among other risks, which are described in their respective prospectuses. Each 2x Daily ETF seeks a return, before fees and expenses, that is either 200% or –200% of the performance of a specified underlying index, commodity futures index or benchmark (the “Target”) for a single day. Each Inverse ETF seeks a return that is –100% of the performance of its Target. Due to the compounding of daily returns a 2x Daily ETF’s or Inverse ETF’s returns over periods other than one day will likely differ in amount and, particularly in the case of the 2x Daily ETFs, possibly direction from the performance of their respective Target(s) for the same period. Hedging costs charged to BetaPro Products reduce the value of the forward price payable to that ETF. Due to the high cost of borrowing the securities of marijuana companies in particular, the hedging costs charged to HMJI are expected to be material and are expected to materially reduce the returns of HMJI to unitholders and materially impair the ability of HMJI to meet its investment objectives. Currently, the manager expects the hedging costs to be charged to HMJI and borne by unitholders will be between 15.00% and 35.00% per annum of the aggregate notional exposure of HMJI’s forward documents. The hedging costs may increase above this range. The manager will publish, on its website, the updated monthly fixed hedging cost for HMJI for the upcoming month as negotiated with the counterparty to the forward documents, based on the then current market conditions. The VIX ETF, which is a 1x ETF, as described in the prospectus, is a speculative investment tool that is not a conventional investment. The VIX ETF’s Target is highly volatile. As a result, the VIX ETF is not intended as a stand-alone long-term investment. Historically, the VIX ETF’s Target has tended to revert to a historical mean. As a result, the performance of the VIX ETF’s Target is expected to be negative over the longer term and neither the VIX ETF nor its target is expected to have positive long-term performance. Investors should monitor their holdings in BetaPro Products and their performance at least as frequently as daily to ensure such investment(s) remain consistent with their investment strategies.

*The indicated rates of return are the historical annual compounded total returns including changes in per unit value and reinvestment of all dividends or distributions and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. The rates of return shown in the table are not intended to reflect future values of the ETF or returns on investment in the ETF. Only the returns for periods of one year or greater are annualized returns.